Literature DB >> 10203543

Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

S Chaves1, M Gadanho, R Tenreiro, J Cabrita.   

Abstract

Metronidazole susceptibility of 100 Helicobacter pylori strains was assessed by determining the inhibition zone diameters by disk diffusion test and the MICs by agar dilution and PDM Epsilometer test (E test). Linear regression analysis was performed, allowing the definition of significant linear relations, and revealed correlations of disk diffusion results with both E-test and agar dilution results (r2 = 0.88 and 0.81, respectively). No significant differences (P = 0.84) were found between MICs defined by E test and those defined by agar dilution, taken as a standard. Reproducibility comparison between E-test and disk diffusion tests showed that they are equivalent and with good precision. Two interpretative susceptibility schemes (with or without an intermediate class) were compared by an interpretative error rate analysis method. The susceptibility classification scheme that included the intermediate category was retained, and breakpoints were assessed for diffusion assay with 5-microg metronidazole disks. Strains with inhibition zone diameters less than 16 mm were defined as resistant (MIC > 8 microg/ml), those with zone diameters equal to or greater than 16 mm but less than 21 mm were considered intermediate (4 microg/ml < MIC </= 8 microg/ml), and those with zone diameters of 21 mm or greater were regarded as susceptible (MIC </= 4 microg/ml). Error rate analysis applied to this classification scheme showed occurrence frequencies of 1% for major errors and 7% for minor errors, when the results were compared to those obtained by agar dilution. No very major errors were detected, suggesting that disk diffusion might be a good alternative for determining the metronidazole sensitivity of H. pylori strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203543      PMCID: PMC84858     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Evaluation of the E test, a novel method of quantifying antimicrobial activity.

Authors:  D F Brown; L Brown
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

2.  Comparison of activity of 10 antibiotics against clinical strains of Helicobacter pylori by three different techniques.

Authors:  K Weiss; M Laverdière; C Restieri
Journal:  Can J Gastroenterol       Date:  1998-04       Impact factor: 3.522

3.  Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

Authors:  T Lambert; F Mégraud; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

5.  In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion.

Authors:  C C Knapp; M D Ludwig; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole.

Authors:  A M Hirschl; M M Hirschl; M L Rotter
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

7.  Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.

Authors:  Y Glupczynski; M Labbé; W Hansen; F Crokaert; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

8.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  The E test for antimicrobial susceptibility testing of Helicobacter pylori.

Authors:  G Cederbrant; G Kahlmeter; A Ljungh
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

10.  Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.

Authors:  A J DeCross; B J Marshall; R W McCallum; S R Hoffman; L J Barrett; R L Guerrant
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more
  12 in total

1.  Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran.

Authors:  Tahereh Falsafi; Fatemeh Mobasheri; Farahnaz Nariman; Mehri Najafi
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

3.  Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.

Authors:  Marinko Marusic; Zarko Babic; Mirjana Nesanovic; Mira Lucijanic-Mlinac; Vesna Stajcar
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Helicobacter pylori antibiotic resistance in Iran.

Authors:  Marjan Mohammadi; Delaram Doroud; Nazanin Mohajerani; Sadegh Massarrat
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

6.  Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection.

Authors:  Zarko Babic; Ivna Svoboda-Beusan; Nastja Kucisec-Tepes; Dragan Dekaris; Rosana Troskot
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

7.  Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.

Authors:  L M Best; D J M Haldane; M Keelan; D E Taylor; A B R Thomson; V Loo; C A Fallone; P Lyn; F M Smaill; R Hunt; C Gaudreau; J Kennedy; M Alfa; R Pelletier; S J O Veldhuyzen Van Zanten
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  In Vitro Inhibition of Helicobacter pylori Growth by Redox Cycling Phenylaminojuglones.

Authors:  Julio Benites; Héctor Toledo; Felipe Salas; Angélica Guerrero; David Rios; Jaime A Valderrama; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-04-24       Impact factor: 6.543

Review 9.  Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Molecules       Date:  2015-04-08       Impact factor: 4.411

10.  Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Authors:  Silvio Kazuo Ogata; Ana Cristina Gales; Elisabete Kawakami
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.